Illumina
ILMN
#1248
Rank
NZ$31.43 B
Marketcap
NZ$205.59
Share price
1.96%
Change (1 day)
25.30%
Change (1 year)

Revenue for Illumina (ILMN)

Revenue in 2024: NZ$7.75 Billion

According to Illumina's latest financial reports the company's current revenue (TTM ) is NZ$7.17 Billion. In 2024 the company made a revenue of NZ$7.75 Billion an increase over the revenue in the year 2023 that were of NZ$7.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Illumina from 2000 to 2024

Annual revenue

Year Revenue Change
2024NZ$7.75 B8.85%
2023NZ$7.12 B-1.34%
2022NZ$7.21 B8.94%
2021NZ$6.62 B47.61%
2020NZ$4.48 B-14.67%
2019NZ$5.26 B5.91%
2018NZ$4.96 B28.24%
2017NZ$3.87 B11.88%
2016NZ$3.46 B6.75%
2015NZ$3.24 B36.52%
2014NZ$2.37 B37.37%
2013NZ$1.72 B23.87%
2012NZ$1.39 B3.23%
2011NZ$1.35 B15.58%
2010NZ$1.17 B27.55%
2009NZ$0.91 B-7.13%
2008NZ$0.98 B106.28%
2007NZ$0.47 B82.76%
2006NZ$0.26 B143.65%
2005NZ$0.10 B51.69%
2004NZ$70.89 M64.37%
2003NZ$43.12 M124.81%
2002NZ$19.18 M220.36%
2001NZ$5.98 M102.71%
2000NZ$2.95 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
NZ$73.15 B 919.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
NZ$11.62 B 62.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.14 B 153.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$40.59 B 465.95%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
NZ$5.61 B-21.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$0.37 B-94.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacific Biosciences
PACB
NZ$0.25 B-96.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA